HomeCompareRETC vs MRK

RETC vs MRK: Dividend Comparison 2026

RETC yields 200000000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RETC wins by $4.875657285131069e+59M in total portfolio value
10 years
RETC
RETC
● Live price
200000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.875657285131069e+59M
Annual income
$487,565,248,955,786,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00
Full RETC calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — RETC vs MRK

📍 RETC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRETCMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RETC + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RETC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RETC
Annual income on $10K today (after 15% tax)
$17,000,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$414,430,461,612,418,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, RETC beats the other by $414,430,461,612,418,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RETC + MRK for your $10,000?

RETC: 50%MRK: 50%
100% MRK50/50100% RETC
Portfolio after 10yr
$2.4378286425655345e+59M
Annual income
$243,782,624,477,893,130,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RETC
No analyst data
Altman Z
-17.9
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RETC buys
0
MRK buys
0
No recent congressional trades found for RETC or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRETCMRK
Forward yield200000000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4.875657285131069e+59M$56.8K
Annual income after 10y$487,565,248,955,786,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00$9,798.13
Total dividends collected$4.875656971401711e+59M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RETC vs MRK ($10,000, DRIP)

YearRETC PortfolioRETC Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$20,000,010,700$20,000,000,000.00$11,206$366.19+$20000.00MRETC
2$37,383,218,970,104,910$37,383,197,570,093,464.00$12,650$502.35+$37383218970.09MRETC
3$65,303,942,472,059,150,000,000$65,303,902,472,014,860,000,000.00$14,407$694.19+$65303942472059152.00MRETC
4$106,615,009,060,306,890,000,000,000,000$106,614,939,185,088,440,000,000,000,000.00$16,585$967.82+$1.0661500906030689e+23MRETC
5$162,672,273,967,082,950,000,000,000,000,000,000$162,672,159,889,023,270,000,000,000,000,000,000.00$19,342$1,363.89+$1.6267227396708296e+29MRETC
6$231,966,340,306,755,300,000,000,000,000,000,000,000,000$231,966,166,247,422,140,000,000,000,000,000,000,000,000.00$22,913$1,947.19+$2.319663403067553e+35MRETC
7$309,138,182,305,146,600,000,000,000,000,000,000,000,000,000,000$309,137,934,101,162,400,000,000,000,000,000,000,000,000,000,000.00$27,662$2,823.89+$3.091381823051466e+41MRETC
8$385,031,777,252,258,400,000,000,000,000,000,000,000,000,000,000,000,000$385,031,446,474,403,340,000,000,000,000,000,000,000,000,000,000,000,000.00$34,159$4,173.35+$3.850317772522584e+47MRETC
9$448,184,411,799,345,900,000,000,000,000,000,000,000,000,000,000,000,000,000,000$448,183,999,815,344,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00$43,337$6,308.80+$4.481844117993459e+53MRETC
10$487,565,728,513,106,900,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000$487,565,248,955,786,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00$56,776$9,798.13+$4.875657285131069e+59MRETC

RETC vs MRK: Complete Analysis 2026

RETCStock

12 ReTech Corporation, together with its subsidiaries, develops, installs, and sells software for retailers in the United States. Its platform includes 12Mirror, an in-store application, which recognizes clothes worn by a person in reflection and takes pictures that are downloadable by the user and sharable through social media; 12Kiosk, an in-store application, which is used for browsing and obtaining information about consumers and products, as well as placing orders and checking out; 12Mobile, a mobile app that is used for browse products, place orders, and share products with other members and make new friends; and 12Desktop, an e-commerce website. The company also operates retail stores in airport terminals and casinos under the Bluwire brand; sells fashionable apparel under the Rune NYC, Social Sunday, and Red Wire Design brands; and produces women's clothing products. 12 ReTech Corporation was founded in 2014 and is based in Phoenix, Arizona.

Full RETC Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this RETC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RETC vs SCHDRETC vs JEPIRETC vs ORETC vs KORETC vs MAINRETC vs JNJRETC vs ABBVRETC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.